15. Mia AS, Koger HD, Tierney MM. Serum values of amylase and pancreatic lipase in healthy mature dogs and dogs with experimental
pancreatitis. Am J Vet Res 1978;39:965-969.
16. Brobst D, Ferguson AB, Carter JM. Evaluation of serum amylase and lipase activity in experimentally induced pancreatitis
in the dog. J Am Vet Med Assoc 1970;157:1697-1702.
17. Strombeck DR, Farver T, Kaneko JJ. Serum amylase and lipase activities in the diagnosis of pancreatitis in dogs. Am J Vet Res 1981;42:1966-1970.
18. Simpson KW, Simpson JW, Lake S, et al. Effect of pancreatectomy on plasma activities of amylase, isoamylase, lipase and trypsin-like
immunoreactivity in dogs. Res Vet Sci 1991;51:78-82.
19. Steiner JM, Gumminger SR, Rutz GM, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentrations in dogs with
exocrine pancreatic insufficiency (abst). J Vet Intern Med 2001;15:274.
20. Polzin DJ, Osborne CA, Stevens JB, et al. Serum amylase and lipase activities in dogs with chronic primary renal failure.
Am J Vet Res 1983;44:404-410.
21. Bedrak E. Blood serum enzyme activity of dogs exposed to heat stress and muscular exercise. J Appl Physiol 1965;20:587-590.
22. Parent J. Effects of dexamethasone on pancreatic tissue and on serum amylase and lipase activities in dogs. J Am Vet Med Assoc 1982;180:743-746.
23. Fittschen C, Bellamy JE. Prednisone treatment alters the serum amylase and lipase activities in normal dogs without causing
pancreatitis. Can J Comp Med 1984;48:136-140.
24. Parent C, Washabau RJ, Williams DA, et al. Serum trypsin-like immunoreactivity, amylase and lipase in the diagnosis of feline
acute pancreatitis (abst). J Vet Intern Med 1995;9:194.
25. Kitchell BE, Strombeck DR, Cullen J, et al. Clinical and pathologic changes in experimentally induced acute pancreatitis
in cats. Am J Vet Res 1986;47:1170-1173.
26. Mansfield CS, Jones BR. Trypsinogen activation peptide in the diagnosis of canine pancreatitis (abst). J Vet Intern Med 2000;14:346.
27. Steiner JM, Broussard J, Mansfield CS, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentrations in dogs
with spontaneous pancreatitis (abst). J Vet Intern Med 2001;15:274.
28. Mansfield CS, Jones BR. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs
with other systemic diseases. Aust Vet J 2000;78:416-422.
29. Allen H, Broussard J, Steiner JM, et al. Comparison of clinical utility of different serum and urinary markers for feline
pancreatitis (abst). J Vet Intern Med 2003;17:411.
30. Steiner JM, Wilson BG, Williams DA. Development and analytical validation of a radioimmunoassay for the measurement of feline
pancreatic lipase immunoreactivity in serum. Can J Vet Res 2004;68:309-314.
31. Steiner JM, Teague SR, Williams DA. Development and analytic validation of an enzyme-linked immunosorbent assay for the measurement
of canine pancreatic lipase immunoreactivity in serum. Can J Vet Res 2003;67:175-182.
32. Steiner JM, Finco DR, Gumminger SR, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) in dogs with experimentally
induced chronic renal failure (abst). J Vet Intern Med 2001;15:311.
33. Steiner JM, Lees GE, Willard MD, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentration is not altered
by oral prednisone (abst). J Vet Intern Med 2003;17:444.
34. Williams DA, Steiner JM, Ruaux CG, et al. Increases in serum pancreatic lipase immunoreactivity (PLI) are greater and of
longer duration than those of trypsin-like immunoreactivity (TLI) in cats with experimental pancreatitis (abst). J Vet Intern Med 2003;17:445-446.
|
Featuring Information from:
